サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541687

吸入用一酸化窒素市場レポート：用途別、地域別、2024年～2032年

Inhaled Nitric Oxide Market Report by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 145 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
吸入用一酸化窒素市場レポート：用途別、地域別、2024年～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

吸入用一酸化窒素市場の世界市場規模は2023年に9億4,370万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに16億5,770万米ドルに達し、2024年から2032年の間に6.3％の成長率（CAGR）を示すと予測しています。

吸入用一酸化窒素（iNO）は、三次新生児集中治療室（NICU）の熟練した医師が監修する選択的肺血管拡張薬です。iNOは、換気と灌流のミスマッチを改善し、肺血管抵抗の上昇と高血圧を軽減することによって、血管筋緊張を調整し、新生児の低酸素性呼吸不全を治療するのに役立ちます。また、酸素化を改善し、体外膜酸素療法（ECMO）の必要性を減少させるのにも役立ちます。現在、急性呼吸窮迫症候群（ARDS）患者の救援薬としてiNO療法の使用が増加しています。

吸入用一酸化窒素市場傾向：

持続性肺高血圧症や新生児低酸素性呼吸不全（HRF）など、新生児における呼吸器疾患やその他の後続疾患の有病率の増加は、市場成長に大きく寄与する主な要因の1つです。さらに、高血圧、アテローム性動脈硬化症、末梢動脈疾患、心不全、血栓症に比較的かかりやすい老人人口の増加が、市場の成長を支えています。さらに、iNOは慢性閉塞性肺疾患（COPD）、喘息、ARDSの治療のために世界中で絶大な支持を得ています。さらに、伝染性の高いコロナウイルス病（COVID-19）の発生と、世界レベルで感染者が驚くほど増加していることが、市場に好影響を与えています。さらに、iNO療法は重症肺炎患者の換気/灌流を改善するのに役立つため、コロナウイルス汚染に対して使用されています。また、全体的な患者体験を向上させるために、世界中のヘルスケア業界で研究開発（R&D）活動が進められていることも市場を牽引しています。

本レポートで扱う主な質問

  • 世界の吸入用一酸化窒素市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19は世界の吸入用一酸化窒素市場にどのような影響を与えているか？
  • 主要地域市場とは？
  • 用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の吸入用一酸化窒素市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の吸入用一酸化窒素市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：用途別

  • 新生児呼吸器治療
    • 市場動向
    • 市場予測
  • 慢性閉塞性肺疾患（COPD）
    • 市場動向
    • 市場予測
  • 急性呼吸窮迫症候群（ARDS）
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第8章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第9章 バリューチェーン分析

第10章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第11章 価格分析

第12章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Air Liquide S.A
    • Bellerophon Therapeutics
    • Beyond Air Inc.
    • Linde plc
    • Mallinckrodt plc
    • Merck KGaA
    • Novoteris LLC
    • Nu-Med Plus
    • VERO Biotech LLC
図表

List of Figures

  • Figure 1: Global: Inhaled Nitric Oxide Market: Major Drivers and Challenges
  • Figure 2: Global: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Inhaled Nitric Oxide Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Inhaled Nitric Oxide Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 7: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 8: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Inhaled Nitric Oxide (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Inhaled Nitric Oxide (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: North America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: North America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: United States: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: United States: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Canada: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Canada: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Asia-Pacific: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Asia-Pacific: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: China: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: China: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Japan: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Japan: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: India: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: India: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: South Korea: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: South Korea: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Australia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Australia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Indonesia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Indonesia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Europe: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Europe: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Germany: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Germany: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: France: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: France: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United Kingdom: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United Kingdom: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Italy: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Italy: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Spain: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Spain: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Russia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Russia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Latin America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Latin America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Brazil: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Brazil: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Mexico: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Mexico: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Middle East and Africa: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Middle East and Africa: Inhaled Nitric Oxide Market: Breakup by Country (in %), 2023
  • Figure 62: Middle East and Africa: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Global: Inhaled Nitric Oxide Industry: SWOT Analysis
  • Figure 64: Global: Inhaled Nitric Oxide Industry: Value Chain Analysis
  • Figure 65: Global: Inhaled Nitric Oxide Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhaled Nitric Oxide Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 3: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 4: Global: Inhaled Nitric Oxide Market: Competitive Structure
  • Table 5: Global: Inhaled Nitric Oxide Market: Key Players
目次
Product Code: SR112024A4100

The global inhaled nitric oxide market size reached US$ 943.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,657.7 Million by 2032, exhibiting a growth rate (CAGR) of 6.3% during 2024-2032.

Inhaled nitric oxide (iNO) refers to a selective pulmonary vasodilator supervised by skilled physicians at tertiary neonatal intensive care units (NICUs). It assists in regulating vascular muscle tone and treating hypoxemic respiratory failure among newly born infants by improving ventilation-perfusion mismatch and reducing elevated pulmonary vascular resistance and hypertension. It also aids in improving oxygenation and decreasing the need for extracorporeal membrane oxygenation (ECMO). At present, there is a rise in the use of iNO therapy as a rescue agent for acute respiratory distress syndrome (ARDS) patients.

Inhaled Nitric Oxide Market Trends:

The increasing prevalence of respiratory and other subsequent diseases in newborns, such as persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), represents one of the primary factors significantly contributing to the market growth. Additionally, the rising geriatric population, which is relatively more prone to hypertension, atherosclerosis, peripheral artery disease, heart failure, and thrombosis, is supporting the growth of the market. Furthermore, iNO is gaining immense traction worldwide for treating chronic obstructive pulmonary diseases (COPD), asthma, and ARDS. Moreover, the outbreak of the highly contagious coronavirus disease (COVID-19) and an alarmingly increasing number of individuals getting infected on a global level are favorably influencing the market. Furthermore, iNO therapy is being used against coronavirus stains as it assists in improving ventilation/perfusion in patients with severe pneumonia. The market is also driven by the ongoing research and development (R&D) activities in the healthcare industry around the world to improve the overall patient experience.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global inhaled nitric oxide market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application.

Breakup by Application:

Neonatal Respiratory Treatment

Chronic Obstructive Pulmonary Disease (COPD)

Acute Respiratory Distress Syndrome (ARDS)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.

Key Questions Answered in This Report:

  • How has the global inhaled nitric oxide market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global inhaled nitric oxide market?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global inhaled nitric oxide market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhaled Nitric Oxide Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Neonatal Respiratory Treatment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Acute Respiratory Distress Syndrome (ARDS)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 United States
      • 7.1.1.1 Market Trends
      • 7.1.1.2 Market Forecast
    • 7.1.2 Canada
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
  • 7.2 Asia-Pacific
    • 7.2.1 China
      • 7.2.1.1 Market Trends
      • 7.2.1.2 Market Forecast
    • 7.2.2 Japan
      • 7.2.2.1 Market Trends
      • 7.2.2.2 Market Forecast
    • 7.2.3 India
      • 7.2.3.1 Market Trends
      • 7.2.3.2 Market Forecast
    • 7.2.4 South Korea
      • 7.2.4.1 Market Trends
      • 7.2.4.2 Market Forecast
    • 7.2.5 Australia
      • 7.2.5.1 Market Trends
      • 7.2.5.2 Market Forecast
    • 7.2.6 Indonesia
      • 7.2.6.1 Market Trends
      • 7.2.6.2 Market Forecast
    • 7.2.7 Others
      • 7.2.7.1 Market Trends
      • 7.2.7.2 Market Forecast
  • 7.3 Europe
    • 7.3.1 Germany
      • 7.3.1.1 Market Trends
      • 7.3.1.2 Market Forecast
    • 7.3.2 France
      • 7.3.2.1 Market Trends
      • 7.3.2.2 Market Forecast
    • 7.3.3 United Kingdom
      • 7.3.3.1 Market Trends
      • 7.3.3.2 Market Forecast
    • 7.3.4 Italy
      • 7.3.4.1 Market Trends
      • 7.3.4.2 Market Forecast
    • 7.3.5 Spain
      • 7.3.5.1 Market Trends
      • 7.3.5.2 Market Forecast
    • 7.3.6 Russia
      • 7.3.6.1 Market Trends
      • 7.3.6.2 Market Forecast
    • 7.3.7 Others
      • 7.3.7.1 Market Trends
      • 7.3.7.2 Market Forecast
  • 7.4 Latin America
    • 7.4.1 Brazil
      • 7.4.1.1 Market Trends
      • 7.4.1.2 Market Forecast
    • 7.4.2 Mexico
      • 7.4.2.1 Market Trends
      • 7.4.2.2 Market Forecast
    • 7.4.3 Others
      • 7.4.3.1 Market Trends
      • 7.4.3.2 Market Forecast
  • 7.5 Middle East and Africa
    • 7.5.1 Market Trends
    • 7.5.2 Market Breakup by Country
    • 7.5.3 Market Forecast

8 SWOT Analysis

  • 8.1 Overview
  • 8.2 Strengths
  • 8.3 Weaknesses
  • 8.4 Opportunities
  • 8.5 Threats

9 Value Chain Analysis

10 Porters Five Forces Analysis

  • 10.1 Overview
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Degree of Competition
  • 10.5 Threat of New Entrants
  • 10.6 Threat of Substitutes

11 Price Analysis

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players
    • 12.3.1 Air Liquide S.A
      • 12.3.1.1 Company Overview
      • 12.3.1.2 Product Portfolio
      • 12.3.1.3 Financials
      • 12.3.1.4 SWOT Analysis
    • 12.3.2 Bellerophon Therapeutics
      • 12.3.2.1 Company Overview
      • 12.3.2.2 Product Portfolio
      • 12.3.2.3 Financials
    • 12.3.3 Beyond Air Inc.
      • 12.3.3.1 Company Overview
      • 12.3.3.2 Product Portfolio
      • 12.3.3.3 Financials
    • 12.3.4 Linde plc
      • 12.3.4.1 Company Overview
      • 12.3.4.2 Product Portfolio
      • 12.3.4.3 Financials
    • 12.3.5 Mallinckrodt plc
      • 12.3.5.1 Company Overview
      • 12.3.5.2 Product Portfolio
      • 12.3.5.3 Financials
    • 12.3.6 Merck KGaA
      • 12.3.6.1 Company Overview
      • 12.3.6.2 Product Portfolio
      • 12.3.6.3 Financials
      • 12.3.6.4 SWOT Analysis
    • 12.3.7 Novoteris LLC
      • 12.3.7.1 Company Overview
      • 12.3.7.2 Product Portfolio
    • 12.3.8 Nu-Med Plus
      • 12.3.8.1 Company Overview
      • 12.3.8.2 Product Portfolio
      • 12.3.8.3 Financials
    • 12.3.9 VERO Biotech LLC
      • 12.3.9.1 Company Overview
      • 12.3.9.2 Product Portfolio